Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in Obesity
Condition: Obesity Interventions: Drug: Dapagliflozin; Drug: Dapagliflozin plus Metformin XR; Drug: Metformin XR Sponsor: University of Guadalajara Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dapagliflozin | Eating Disorders & Weight Management | Fortamet | Forxiga | Metformin | Obesity